Midwest Capital Advisors’s DexCom DXCM Stock Holding History

Midwest Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-700	Closed	-$47.1K	–	198
2025 Q3	$47.1K	Hold	700	–	–	0.02%	88
2025 Q2	$61.1K	Hold	700	–	–	0.03%	76
2025 Q1	$47.8K	Hold	700	–	–	0.03%	88
2024 Q4	$54.4K	Buy	+700	New	+$51.8K	0.04%	86

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Midwest Capital Advisors's DXCM Position: Q4 2025 in Review

Midwest Capital Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 700 shares — an estimated $47.1K sold.

Midwest Capital Advisors first reported a position in DXCM in Q4 2024 and held it in 4 quarters. The position peaked at $61.1K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Midwest Capital Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Midwest Capital Advisors sold 700 DexCom shares in Q4 2025, an estimated $47.1K.
Midwest Capital Advisors first reported a position in DexCom in Q4 2024 and held it in 4 quarters.
Midwest Capital Advisors's DexCom position peaked at $61.1K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Midwest Capital Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.